azacitidine and Genetic Skin Diseases

azacitidine has been researched along with Genetic Skin Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aouba, A; Bouscary, D; Comont, T; Dion, J; Fenaux, P; Georgin-Lavialle, S; Heiblig, M; Kosmider, O; Le Guenno, G; Mathian, A; Mekinian, A; Rieu, V; Rivière, E; Rossignol, J; Terrier, B; Terriou, L; Vinit, J	1

Other Studies

1 other study(ies) available for azacitidine and Genetic Skin Diseases

Article	Year
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. British journal of haematology, 2022, Volume: 196, Issue:4 Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Female; France; Genes, X-Linked; Genetic Diseases, X-Linked; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Registries; Skin Diseases, Genetic	2022

Article

Year

Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.

British journal of haematology, 2022, Volume: 196, Issue:4

Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Female; France; Genes, X-Linked; Genetic Diseases, X-Linked; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Registries; Skin Diseases, Genetic

2022